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Introduction  
Intraaortic balloon pumping (IABP) is an established treatment for the support 
of a failing heart (Christenson, Simonet et al. 1997). It is a process undertaken 
in most level two and three intensive care units. Despite IABP appearing 
complex, the principles are straightforward. A sausage shaped intraaortic 
balloon (IAB) about 250 millimetres long and 15 millimetres in diameter, is 
placed in the descending aorta and attached to an external pump. The external 
pump then inflates and deflates the IAB in synchrony with cardiac contraction. 
The primary purpose of this is the support of a compromised heart with a 
simultaneous increase in myocardial oxygen supply, and decrease in 
myocardial oxygen demand (Overwalder, 1999). As a nurse it is worthwhile 
understanding the principles of IABP. As a hospital intervention, it’s exposure 
to nursing is high. 
 
Physiology 
The IAB is inflated at the onset of diastole when blood ceases to eject from the 
heart. Inflation of the IAB results in displacement of blood volume within the 
descending thoracic aorta. Proximal blood is returned to the heart to oxygenate 
the coronary arteries while blood in the distal descending aorta is circulated 
around the body. IAB deflation, however, is timed to occur immediately prior 
to the onset of systole before the heart commences ejection. This ensures 
afterload is reduced and blood is ejected into a partially empty aorta. Cardiac 
workload and the consequent demand for oxygen can thus be reduced. This 
reduction in afterload also improves cardiac output and increases systemic 
perfusion (Overwalder, 1999).    
 
Primarily IABP increases myocardial oxygen supply and decreases myocardial 
oxygen demand. Secondarily IABP improves cardiac output, increases 
coronary perfusion pressures, increases systemic perfusion, reduces mitral 
regurgitation and reduces afterload which will subsequently decrease left 
ventricular workload (Bolooki 1989; Overwalder 1999).  
 
Mechanics 
The adult IAB is available in three sizes: 34 millilitre balloon volume; 40 
millilitre balloon volume; and 50 millilitre balloon volume (Krau, 1999). When 
the IAB is inflated it has a diameter of 15 millimetres (Datascope 2002). IABP 
requires the positioning of an IAB in the descending thoracic aorta (see figure 
1). The IAB is located immediately inferior to the origin of the left subclavian 
artery and superior to the renal arteries (Overwalder, 1999). The IAB is then 
attached to an external pump used to inflate and deflate the IAB in synchrony 
with cardiac contractions (Overwalder, 1999).   
 
Historical background 
Diastolic augmentation to assist in the treatment of left ventricular failure was 
described for the first time in 1958 (Harken, 1958). Harken suggested that the 
removal of blood from the femoral artery during systole and it’s rapid 
replacement during diastole would both assist cardiac output and unload the 
heart simultaneously (Harken, 1958, 1976). Considering these principles an 
IAB prototype was developed in 1962 and integrated into client care in 1968 
(Kantrowitz, Tjonneland, & Freed, 1968; Moulopoulos, Topaz, & Kolff, 1962). 
This experience was mixed, demonstrating an improvement in haemodynamic 
function but no significant alteration in mortality rate.   
 
IAB development has continued since 1962 and practice has consequently 
changed dramatically. Technological advance has allowed easier IAB insertion, 
the provision of  a smaller IAB and a more efficient external pump. Greater 
circulatory benefits and fewer complications are the result. Time has also seen 
the change in IABP indications. 
 
Indications  
Accepted guidelines for IABP include: cardiogenic shock; left ventricular 
failure; stunned myocardium; myocardial contusion; unstable angina; failure to 
separate from cardiopulmonary bypass; procedural support during coronary 
angiography and angioplasty; bridging to heart transplantation; septic shock; 
drug induced cardiovascular failure; and prophylactic application in the event 
of preoperative surgery especially cardiac surgery or myocardial infarction 
(Overwalder, 1999). IABP has also been used successfully in the treatment of 
clients to augment cerebral blood flow in the setting of cerebral vasospasm, in 
the anaesthetic management of high risk cardiac clients undergoing non cardiac 
surgery and for the management of myocardial failure after severe post partum 
haemorrhage (Apostolides, Greene, Zabramski, Fitzgerald, & Spetzler, 1996; 
Masaki et al., 1999; Mayr et al., 1999; Nussbaum et al., 1995; Nussbaum, 
Sebring, Ganz, & Madison, 1998; Rosen, Sekhar, Duong, Seifert, & Persson, 
2000; Sanborn et al., 2000).     
 
Complications 
IABP is not without risk. Over recent times technological advance has been 
responsible for a  dramatic decrease in complication rates. Despite these 
advances, complications remain numerous. These include: limb ischaemia; 
platelet activation; thromboembolism; aortic dissection; infection; IAB rupture; 
IAB entrapment; and vascular injury – false aneurism at the catheter insertion 
site, arterial perforation, and renal or abdominal organ dysfunction (Haas 
Stavarski, 1996; Shin, Yozu, Sumida, & Kawada, 2000; Vonderheide, 
Thadhani, & Kuter, 1998).   
 
Nursing care of the IABP patient 
Principles of IABP may be reasonably simple, however, nursing care of a 
patient subject to this intervention can be a complex task. While care of the 
IABP creates a new nursing challenge it is the secondary problem of heart 
failure which complicates care. Inadequate heart function will compromise any 
bodily system reliant on adequate cardiac function. The impairment of the 
hearts ability to pump causes a decrease in blood pressure and the consequent 
onset of shock. The complications of shock are those which complicate nursing 
care. The patient is often mechanically ventilated, is almost certain to be 
receiving a medley of pharmacological support (e.g. inotropes to support the 
heart such as adrenaline; vasopressors to support the blood pressure and 
peripheral perfusion such as GTN; diuretics to prevent renal failure such as 
frusemide) and will be restricted to bed rest as a consequence of the IABP. The 
nurse is required to combine vigilance with careful and methodical assessment 
skills to care for this patient adequately.  
 
In caring for patients receiving IABP the nurse must make sound clinical 
assessments and ensure accurate and consistent observations. Assessments and 
observations which must be undertaken are those specific to cardiac function, 
the IABP process and possible IABP complications. Assessments include: 
blood pressure; heart rate; urine output; mentation; peripheral perfusion; lung 
function; and fluid replacement requirements. Blood should be drawn regularly 
to monitor electrolytes and clotting. Hourly documentation of these 
assessments provides a picture as to how the patient is progressing informing 
future patient cares. Documentation in addition to assessments should include 
the function of the external pump (the frequency which it inflates the IAB, and 
the augmentation it provides the IAB and systolic blood pressure) and dosage 
of any pharmacological interventions.    
 
While specific skills are required to care for the IABP, the ventilator, multiple 
infusions and drains, the nurse must not lose sight of the human element of 
nursing. The nurse should not merely care and tend the interventions and 
procedures but also care and tend the patient. A patient must have confidence 
in the nurse, must trust and feel reassured by the nurse and must be continually 
educated by the nurse. This nurse/patient partnership which is so evident in 
general nursing must not be lost as the complexity of care increases.  
 
 
Summary 
It remains the responsibility of any nurse to assume accountability for their 
cares. Understanding the physiology and process behind any intervention  
improves patient cares while also increasing nursing satisfaction and skill. 
IABP is no exception. An awareness of IABP will facilitate sound nursing care, 
ensure early identification of possible complications or patient compromise, 
and warrant patient and relative satisfaction. It will also assist in the transition 
of caring for a patient subject to this ‘complex’ medical intervention.  
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Figure 1. Location of the intraaortic balloon (in this figure the intraaortic 
balloon is deflated). 
   
This figure has been downloaded from the web. If there are copyright issues I 
am able to draw a diagram similarly depicting IABP.   
 
Despite the complexity of any situation the process of nursing care should 
remain the same. Good nursing is based around sound assessment skills (on 
which future interventions will be based), accurate and consistent observations 
(which demonstrate stability of the patient condition) and a desire to do what is 
in the patients best interest (problem rectification will not necessarily heal a 
patient).  
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